ResearcherUniversidad Francisco de VitoriaActive in the last 2 years
Vilma Pacheco-Barcía
Matched on ORCID iD 0000-0003-0141-1306; OpenAlex author ID A5067529860. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers
Papers 6
- Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort. Co-author DOI 10.1007/s12094-026-04554-8↗
- Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic re… First author DOI 10.1016/j.ctrv.2026.103174↗
- Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Last author DOI 10.1016/j.pan.2026.08.008↗
- Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. Co-author DOI 10.4251/wjgo.v16.i2.386↗
- A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.12.010↗
- A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001294↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrés Jesús Muñoz Martín · 3 shared papers, 2024–2026 · strength 0.73
- Paper Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreati… DOI 10.1016/j.ctrv.2026.103174↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Luis Cabezón‐Gutiérrez · 3 shared papers, 2024–2026 · strength 0.73
- Paper Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreati… DOI 10.1016/j.ctrv.2026.103174↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Alberto Carmona‐Bayonas · 3 shared papers, 2024–2026 · strength 0.66
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Javier Gallego-Plazas · 3 shared papers, 2024–2026 · strength 0.66
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Ángela Lamarca · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Elena Brozos-Vázquez · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Carmen Guillén‐Ponce · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Beatriz Chacón-Ovejero · 1 shared paper, 2026 · strength 0.30
- Ismael Ghanem · 1 shared paper, 2026 · strength 0.23
- Rámón Colomer · 2 shared papers, 2019–2020 · strength 0.19
- Paper A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX… DOI 10.1016/j.pan.2019.12.010↗
- Paper A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer. DOI 10.1097/mpa.0000000000001294↗
- George Zogopoulos · 2 shared papers, 2019–2020 · strength 0.19
- Paper A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX… DOI 10.1016/j.pan.2019.12.010↗
- Paper A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer. DOI 10.1097/mpa.0000000000001294↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.